Authors

Stephen J. Beebe, The Frank Reidy Center for Bioelectrics
Michael J. Celestine, Department of Chemistry and Biochemistry, Old Dominion University
Jimmie L. Bullock, Department of Chemistry and Biochemistry, Old Dominion University
Shayna Sandhaus, Department of Chemistry and Biochemistry, Biomolecular Sciences Institute, Florida International University, 11200 SW 8th St., Miami, FL 33199, USA.Follow
Jessa Faye Arca, Department of Chemistry and Biochemistry, The University of Southern Mississippi
Donald M. Cropek, U.S. Army Corps of Engineers, Construction Engineering Research Laboratory
Tekettay A. Ludvig, Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, VA 23529, USA.
Sydney R. Foster, Department of Chemistry and Biochemistry, Old Dominion University
Jasmine S. Clark, Department of Chemistry and Biochemistry, Old Dominion University
Floyd A. Beckford, The University of Virginia's College at Wise
Criszcele M. Tano, Department of Chemistry and Biochemistry, Old Dominion University
Elizabeth A. Tonsel-White, Department of Chemistry and Biochemistry, Old Dominion University
Raj K. Gurung, Department of Chemistry and Biochemistry, Old Dominion University
Courtney E. Stankavich, Department of Chemistry and Biochemistry, Old Dominion University
Yuk-Ching Tse-Dinh, Department of Chemistry and Biochemistry, Biomolecular Sciences Institute, Florida International UniversityFollow
William L. Jarrett, School of Polymers and High-Performance Materials, The University of Southern Mississippi
Alvin A. Holder, Department of Chemistry and Biochemistry, Old Dominion University

Date of this Version

2-1-2020

Document Type

Article

Rights

default

Abstract

In this study, 9-anthraldehyde-N(4)-methylthiosemicarbazone (MeATSC) 1 and [Co(phen)(OCO)]Cl·6HO 2 (where phen = 1,10-phenanthroline) were synthesized. [Co(phen)(OCO)]Cl·6HO 2 was used to produce anhydrous [Co(phen)(HO)](NO)3. Subsequently, anhydrous [Co(phen)(HO)](NO)3 was reacted with MeATSC 1 to produce [Co(phen)(MeATSC)](NO)·1.5HO·CHOH 4. The ligand, MeATSC 1 and all complexes were characterized by elemental analysis, FT IR, UV-visible, and multinuclear NMR (H, C, and Co) spectroscopy, along with HRMS, and conductivity measurements, where appropriate. Interactions of MeATSC 1 and complex 4 with calf thymus DNA (ctDNA) were investigated by carrying out UV-visible spectrophotometric studies. UV-visible spectrophotometric studies revealed weak interactions between ctDNA and the analytes, MeATSC 1 and complex 4 (K = 8.1 × 10 and 1.6 × 10 M, respectively). Topoisomerase inhibition assays and cleavage studies proved that complex 4 was an efficient catalytic inhibitor of human topoisomerases I and IIα. Based upon the results obtained from the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay on 4T1-luc metastatic mammary breast cancer cells (IC = 34.4 ± 5.2 μM when compared to IC = 13.75 ± 1.08 μM for the control, cisplatin), further investigations into the molecular events initiated by exposure to complex 4 were investigated. Studies have shown that complex 4 activated both the apoptotic and autophagic signaling pathways in addition to causing dissipation of the mitochondrial membrane potential (ΔΨ). Furthermore, activation of cysteine-aspartic proteases3 (caspase 3) in a time- and concentration-dependent manner coupled with the ΔΨ, studies implicated the intrinsic apoptotic pathway as the major regulator of cell death mechanism.

DOI

10.1016/j.jinorgbio.2019.110907

Identifier

31715377

Comments

J Inorg Biochem. Author manuscript; available in PMC 2020 Mar 3. Published in final edited form as: J Inorg Biochem. 2020 Feb; 203: 110907. Published online 2019 Nov 2. doi: 10.1016/j.jinorgbio.2019.110907

Share

COinS
 

Rights Statement

Rights Statement

In Copyright. URI: http://rightsstatements.org/vocab/InC/1.0/
This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).